- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06003439
Vaping Prevention and Vaping in Youth (Vapechat) (Vapechat)
Virtual Reality for the Prevention and Cessation of Nicotine Vaping in Youth
Many youth are addicted to nicotine due to increased nicotine vaping (e.g., e-cigarettes). Unfortunately, there are no effective interventions to help teens quit vaping. In addition, existing vaping prevention programs have limited effectiveness because teens have reported that existing available interventions are out of touch with teen's culture and are not appealing to the intended audience. Therefore, to be effective, a vaping intervention must be acceptable, appealing, and engaging to teens, and most importantly, it should be designed to be channeled into an existing infrastructure such as the school setting.
The investigators' research group has designed a vaping prevention and cessation intervention that is implemented as a VR game for high school teens. The overall objective of this research is to assess the acceptability, feasibility, and preliminary efficacy of the VR experience among high school students in two high schools in Boston.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators will conduct a randomized trial of high school students (freshman to seniors) in the Boston area to determine feasibility, satisfaction, and preliminary efficacy of the VR-based vaping cessation and prevention game. Students will be randomized by class to either receive the Virtual Reality (VR) program (experimental condition) or control condition (questionnaire assessment only). There will be three VR sessions played at school during a health class. Participants in the VR condition will also engage in a gamified home-based component on their smartphone, in order to reinforce skills learned in the school-based VR experience.
Seven high school classes across two high schools will be randomized to VR intervention or assessment only. Health classes in each high school will be randomly assigned using a 1:3 threshold probability using a random digit generator. Participants will be enrolled in the study for approximately 6 weeks. In the first 3 weeks, participants will engage in the VR game experience once per week during their classes. In the fourth and fifth week, participants may make up any VR game session that they missed because of absence (e.g., illness). At week 6, participants will complete the follow-up questionnaire assessments.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- Boston University, Goldman School of Dental Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Students enrolled at Everett and Quincy High Schools (freshmen, sophomores, juniors, and seniors).
- Students in Health class
- Child assents
Exclusion Criteria:
- Teacher indicates that participation is not appropriate for the student (e.g., severe mental illness; visual or auditory disability; medical issue)
- Parent(s)/guardian(s) opt student out of the study.
- Prone to motion sickness or seizures.
- Visual impairments that would preclude playing VR or otherwise unable to use VR device.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Virtual Reality Program
Students in classrooms randomized to this group will receive the Virtual Reality vaping cessation and prevention program.
|
Behavioral: Virtual Reality Program The VR Program will be pre-installed on Meta Quest 2 headsets, which will be donned by students as a class to experience the intervention for approximately the length of one school class period (approximately 30-40 minutes).
Each participant will experience the program once a week for 3 weeks.
Participants who missed a week will complete the program by the 4th or 5th week.
Other Names:
VR program participants will be able to download a mobile app that complements and reinforces the school-based VR session.
|
|
No Intervention: Assessment Only
Students in classrooms randomized to this group will not receive the VR intervention but will complete questionnaire assessment only.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Engagement with the VR program
Time Frame: 5 weeks
|
Experimental condition arm.
Playing time in minutes objectively measured by the program software; higher values mean a better outcome
|
5 weeks
|
|
Satisfaction with the VR game
Time Frame: 5 weeks
|
Experimental condition arm.
Self-report star rating of the VR game (1 to 5 stars); higher values mean a better outcome
|
5 weeks
|
|
Awareness of vaping
Time Frame: 5 weeks
|
Experimental condition arm.
Self-report awareness adapted from the Mobile App Rating Scale (MARS).
Score range 1 - 5; higher values mean a better outcome
|
5 weeks
|
|
Knowledge of vaping
Time Frame: 5 weeks
|
Experimental condition arm Self-report knowledge adapted from the Mobile App Rating Scale (MARS).
Score range 1 - 5; higher values mean a better outcome
|
5 weeks
|
|
Attitudes towards vaping
Time Frame: 5 weeks
|
Experimental condition arm.
Self-report attitudes towards vaping adapted from the Mobile App Rating Scale (MARS).
Score range 1 - 5; higher values mean a better outcome
|
5 weeks
|
|
Intention to change
Time Frame: 5 weeks
|
Experimental condition arm.
Self-report intention to change vaping behaviors adapted from the Mobile App Rating Scale (MARS).
Score range 1 - 5; higher values mean a better outcome
|
5 weeks
|
|
Help seeking
Time Frame: 5 weeks
|
Experimental condition arm.
Self-report help seeking for vaping behaviors adapted from the Mobile App Rating Scale (MARS).
Score range 1 - 5; higher values mean a better outcome
|
5 weeks
|
|
Gameplay experience and satisfaction
Time Frame: 5 weeks
|
Experimental condition arm.
Scores on a scale assessing the gameplay experience.
Score range 1 - 4; higher values mean a better outcome
|
5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quit vaping attempts
Time Frame: 5 weeks
|
Proportion of participants who have made one or more attempts to quit vaping for at least 24 hours
|
5 weeks
|
|
Past 30-days vaping frequency
Time Frame: 5 weeks
|
Proportion of participants who have vaped '0', or '1-2', or '3-5', or '6-9', or '10-19', or '20-30' days in the past 30-days
|
5 weeks
|
|
Past 7-days vaping frequency
Time Frame: 5 weeks
|
Proportion of participants who have vaped '0', or '1-2', or '3-4', or '5-6', or '7' days in the past 7-days
|
5 weeks
|
|
Frequency of current vaping
Time Frame: 5 weeks
|
Proportion of participants who currently vape 'not at all', or 'some days', or 'most days', or 'every day'
|
5 weeks
|
|
Motivation to quit (or avoid) vaping within the next 30-days
Time Frame: 5 weeks
|
Proportion of participants who are seriously thinking about quitting (or avoid) vaping within the next 30-days
|
5 weeks
|
|
Motivation to quit (or avoid) vaping
Time Frame: 5 weeks
|
Scores on a scale assessing motivation to quit (or avoid) vaping.
Score range 1 - 10; higher values mean a better outcome
|
5 weeks
|
|
Intention to try vaping (or quit vaping)
Time Frame: 5 weeks
|
Proportion of participants who are 'probably not' or 'definitely not' thinking of vaping in the next 30- days
|
5 weeks
|
|
Confidence in avoiding vaping
Time Frame: 5 weeks
|
Scores on a single item assessing confidence in avoiding vaping within 30-days.
Scores range 1-10, higher values mean a better outcome
|
5 weeks
|
|
Tolerability of the VR game
Time Frame: 5 weeks
|
Experimental condition arm Scores on the VR sickness questionnaire.
Scores range 1-4, higher values mean a worse outcome
|
5 weeks
|
|
Intention to connect with vaping cessation resources
Time Frame: 5 weeks
|
Scores on a single item assessing intentions to connect with vaping cessation resources.
Scores range 1-10, higher values mean a better outcome
|
5 weeks
|
|
Connection with vaping cessation resources
Time Frame: 5 weeks
|
Proportion of participants who have made contact with any vaping cessation resources during the study
|
5 weeks
|
|
Self-efficacy to resist vaping
Time Frame: 5 weeks
|
Scores on the adapted smoking abstinence self-efficacy questionnaire for adolescents.
Scores range 0-24 , higher values mean a better outcome
|
5 weeks
|
|
Resilience
Time Frame: 5 weeks
|
Scores on a brief resilience scale.
Scores range 0-3 , higher values mean a worse outcome
|
5 weeks
|
|
Positive affect
Time Frame: 5 weeks
|
Scores on the Pediatric Positive Affect (PROMIS) scale.
Scores range 8-40, higher values mean a better outcome
|
5 weeks
|
|
Negative affect
Time Frame: 5 weeks
|
Scores on the Negative Affect for Children scale Scores range 10-50, higher values mean a worse outcome
|
5 weeks
|
|
Emotion Regulation and Coping
Time Frame: 5 weeks
|
Scores on the Adolescent-Coping Orientation for Problem Experience (A-COPE).
Scores range 6-30, higher values mean a better outcome
|
5 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Belinda Borrelli, PhD, Boston University, Goldman School of Dental Medicine, Center for Behavioral Science Research
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- H-43102
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
National University of SingaporeRecruitingSmoking &Amp; Tobacco CessationSingapore
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSmoking &Amp; Tobacco CessationUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Sultan Qaboos UniversityCompletedSmoking Cessation | Tobacco Use Cessation | Smoking PreventionOman
-
The University of Hong KongCompletedSmoking Cessation Counseling Ability | Smoking Cessation Counseling PracticeHong Kong
Clinical Trials on Virtual Reality Program
-
Yonsei UniversityUnknownStroke | NeglectKorea, Republic of
-
Abramson Cancer Center at Penn MedicineCompleted
-
Germans Trias i Pujol HospitalUnknownEmergence Delirium | Preoperative Anxiety | Maladaptive Postoperative BehaviorSpain
-
Umm Al-Qura UniversityUniversity of HailCompletedCerebral PalsySaudi Arabia
-
University of Massachusetts, LowellSpaulding Rehabilitation Hospital; Hugo W. Moser Research Institute at Kennedy...Completed
-
Kirsehir Ahi Evran UniversitesiCompletedNeck Pain | Rehabilitation | Virtual RealityTurkey
-
University of VictoriaMeta Platforms, Inc.CompletedPhysical Activity | Mental Health | Mood | Well-Being, PsychologicalCanada
-
Instituto de Investigación Sanitaria AragónUniversidad de Zaragoza; Universidad San JorgeActive, not recruitingPhysical Therapy | Parkinson Disease (PD) | Immersive Virtual RealitySpain
-
University of British ColumbiaTerminatedStroke | Stroke, Ischemic | Stroke Hemorrhagic | Stroke, LacunarCanada
-
Universidad Miguel Hernandez de ElcheUniversidad Complutense de MadridRecruitingBurnout, Student | Mental Health Wellness | University Students | Occupational BalanceSpain